In solid tumors, BST‐2 expression is elevated in head and neck cancer 120, lung cancer 121, breast cancer 119, 122, 123, cervical cancer 124, myelomas 125, 126, endometrial cancer 127, and glioblastoma 128. Here, BST2 is linked to lung carcinoma.